genetically engineered hematopoietic stem cells
Cell therapyexperimental
Clinical trial activity
2 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 22, 2012 (NCT01331018)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- genetically engineered hematopoietic stem cells
- genetically engineered hematopoietic stem/progenitor cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03157804 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2016 | CIEMAT, Hospital Infantil Universitario Niño Jesús, Madrid, Spain, Universidad Autonoma de Barcelona, Universidad Autonoma de Madrid |
| NCT01331018 | Phase 1 | Feb 22, 2012 | National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), Rocket Pharma Limited, University of Washington |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CIEMAT | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Hospital Infantil Universitario Niño Jesús, Madrid, Spain | Academic/Hospital | 1 | 1 | 1 | 2016 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2012 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2012 |
| Rocket Pharma Limited | For profit | 1 | 0 | 1 | 2012 |
| Universidad Autonoma de Barcelona | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Universidad Autonoma de Madrid | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Washington | Academic/Hospital | 1 | 1 | 1 | 2012 |
8 organizations
Page 1 / 1